⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11074596 | 0.94 | — | — | |
| SCHEMBL239887 | 0.94 | — | — | |
| SCHEMBL3440747 | 0.94 | — | — | |
| SCHEMBL2161449 | 0.84 | — | — | |
| SCHEMBL14481097 | 0.80 | — | — | |
| SCHEMBL17478307 | 0.80 | TRIM24 (0.31) | — | |
| SCHEMBL136351 | 0.76 | — | — | |
| SCHEMBL170119 | 0.73 | — | — | |
| SCHEMBL17533951 | 0.72 | — | — | |
| SCHEMBL8997440 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1849 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119219557-A | Preparation method of beta, gamma-unsaturated nitrile compound | 苏州大学 | 2024-12-31 | — | — | CN | claimed |
| EP-4389745-A1 | PYRIDONE COMPOUND HAVING INTEGRASE INHIBITORY ACTIVITY AND PHARMACEUTICAL USE THEREOF | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) | 2024-06-26 | — | — | EP | claimed |
| CN-118201930-A | WEE1 protein kinase degradation agent and application thereof | 杭州格博生物医药有限公司 | 2024-06-14 | — | — | CN | claimed |
| EP-4375277-A1 | LPA1 SMALL MOLECULE ANTAGONIST | Tuojie Biotech (Shanghai) Co., Ltd. (CN) | 2024-05-29 | — | — | EP | claimed |
| WO-2024107686-A1 | MACROCYCLIC KRAS INHIBITORS AND METHODS OF USE | AMGEN INC. (US) | 2024-05-23 | — | — | WO | claimed |
| CN-118027260-A | High-selectivity polymer material with adjustable repeating unit carbon skeleton structure and preparation method thereof | 大连理工大学 | 2024-05-14 | — | — | CN | claimed |
| WO-2024088296-A1 | PIPERIDINOPYRIMIDINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE | 上海拓界生物医药科技有限公司 | 2024-05-02 | — | — | WO | claimed |
| CN-117886814-A | PD-1/PD-L1 small molecule inhibitor and application thereof in medicines | 广东东阳光药业股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117715908-A | Pyridone compounds having integrase inhibitory activity and their pharmaceutical use | 江苏恒瑞医药股份有限公司 | 2024-03-15 | — | — | CN | claimed |
| WO-2024027814-A1 | COMPOUND HAVING KRAS G12D INHIBITORY EFFECT | 杭州中美华东制药有限公司 | 2024-02-08 | — | — | WO | claimed |
| WO-1995009826-A1 | PROCESS FOR THE PREPARATION OF METHYLENECYCLOPROPANE | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1995-04-13 | — | — | WO | claimed |
| EP-0641356-A1 | INHIBITORS OF 5-ALPHA-TESTOSTERONE REDUCTASE | GLAXO WELLCOME INC. (US) | 1995-03-08 | — | — | EP | claimed |
| WO-1994014833-A2 | SUBSTITUTED 6-AZAANDROSTENONES | GLAXO WELLCOME INC. (US) | 1994-07-07 | — | — | WO | claimed |
| WO-1994000432-A1 | ANORECTIC EPINEPHRINE DERIVATIVES | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-01-06 | — | — | WO | claimed |
| WO-1993013124-A1 | INHIBITORS OF 5-ALPHA-TESTOSTERONE REDUCTASE | GLAXO INC. (US) | 1993-07-08 | — | — | WO | claimed |
| EP-0152027-B1 | PROCESS FOR THE PREPARATION OF 3-METHYL-2-BUTEN-4-OLIDE(4-METHYL-2-(5H)-FURAN-2-ONE) | Studiengesellschaft Kohle mbH (DE) | 1990-04-11 | — | — | EP | claimed |
| US-4659843-A | Process for preparing 3-methyl-2-butene-4-olide (4-methyl-2(5H)-furane-2-one) | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 1987-04-21 | — | — | US | claimed |
| US-4632996-A | FORMING PI-ALLYL PALLADIUM COMPOUNDS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1986-12-30 | — | — | US | claimed |
| EP-0152027-A2 | Process for the preparation of 3-methyl-2-buten-4-olide(4-methyl-2-(5H)-furan-2-one) | Studiengesellschaft Kohle mbH (DE) | 1985-08-21 | — | — | EP | claimed |
| US-4242278-A | Process for the preparation of 2-(2',2',2'-trihalogenoethyl)-4-halogenocyclobutan-1-ones | CIBA-GEIGY CORPORATION (US) | 1980-12-30 | — | — | US | claimed |